EUVIMEDEUVIMED entdecken
Crossref

Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry

Montserrat Guasch iD, Margalida Calafat, Carla J Gargallo-Puyuelo, Ruth De Francisco iD, Irene Moraleja, Pablo Vega, Luisa de Castro, Fernando Labarga, Francisco Mesonero iD, Jesús Castro-Poceiro, Angel Ponferrada-Díaz, Eduard Brunet-Mas iD und 19 weitere

Inflammatory Bowel Diseases · 01.11.2026 · 32 (11) · 2169-2178

DOI: 10.1093/ibd/izag120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 21.06.2026. Verfasst von Montserrat Guasch und 30 weiteren Autor:innen. Beteiligte Einrichtung: Digestive and General Surgery Department, Hospital de Viladecans, Viladecans, Spain. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Anus Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: ENEIDA, GETECCU, AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Perianal disease (PD) may occur in ulcerative colitis (UC), but scarce data on its features, clinical course, and common therapeutic approach are available. Our aim was to describe the prevalence, clinical characteristics and therapeutic requirements of PD among patients with UC.

Methods

Patients with UC and PD were identified from the ENEIDA registry of GETECCU. Epidemiological, clinical, and therapeutic data were retrospectively gathered and reviewed from medical records.

Results

From a total cohort of 9884 patients with UC, 411 developed PD, leading to an incidence rate of 0.5 cases per 100 person-years. Ninety-one patients (22%) developed PD before being diagnosed with UC. The most common perianal lesions at clinical presentation were fissures (52%), followed by fistulae (44%), and abscesses (39%). In the logistic regression analysis, male gender (OR 1.32 [95% CI, 1.10-1.58]; P = .002) and extra-intestinal manifestations (OR 1.88 [95% CI, 1.39-2.52]; P < .0001) were risk factors for PD, whereas ulcerative proctitis (OR 0.66 [95% CI, 0.51-0.86]; P = .002) was the only protective factor. Surgical techniques were used in 44% of patients with PD, and biologicals were indicated due to PD in 12%. Overall, the rate of PD remission was 91%.

Conclusions

Approximately 4% of patients with UC develop PD, occurring before the diagnosis of UC in one fourth. PD seems to behave less aggressively than in Crohn’s disease, being easily managed conservatively or with perianal surgery and needing biological agents only in a minority of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeAnus DiseasesHumansMaleFemaleRegistriesAdultRetrospective StudiesMiddle AgedRisk FactorsIncidencePrevalenceAbscessPrognosisRectal FistulaYoung AdultFollow-Up StudiesAged

Stichwörter der Autor:innen

abscessfistulaperianal diseaseulcerative colitis

Autor:innen und Institutionen

  • Digestive and General Surgery Department, Hospital de Viladecans, Viladecans, Spain.
  • Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Centro de Investigación Biomédica en red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain.
  • Gastroenterology Department, Hospital Clínico Lozano Blesa and IIS Aragón, Zaragoza, Spain.
  • Gastroenterology Department, Hospital Universitario Central Asturias, Oviedo, Spain.
  • Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Spain.

ORCID-Profile: Montserrat Guasch, Ruth De Francisco, Francisco Mesonero, Eduard Brunet-Mas, Laura Ramos, Yamile Zabana, Elena Ricart, Eugeni Domènech

Förderung

  • ENEIDA
  • GETECCU
  • AbbVie
  • Lilly
  • Pfizer
  • Alfasigma

Zitieren

APA

Guasch, M., Calafat, M., Gargallo-Puyuelo, C. J., De Francisco, R., Moraleja, I., Vega, P., de Castro, L., Labarga, F., Mesonero, F., Castro-Poceiro, J., Ponferrada-Díaz, A., Brunet-Mas, E., Sesé, E., Ramos, L., Quiñones, M., Ruiz-Cerulla, A., Castro, B., Zabana, Y., Iglesias, E., …, & PERICO-ENEIDA Study of the GETECCU (2026). Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry. Inflammatory Bowel Diseases, 32(11), 2169-2178. https://doi.org/10.1093/ibd/izag120

Vancouver

Guasch M, Calafat M, Gargallo-Puyuelo CJ, De Francisco R, Moraleja I, Vega P, et al. Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry. Inflammatory Bowel Diseases. 2026;32(11):2169-2178. doi:10.1093/ibd/izag120

BibTeX
@article{Guasch2026,
  author = {Guasch, Montserrat and Calafat, Margalida and Gargallo-Puyuelo, Carla J and De Francisco, Ruth and Moraleja, Irene and Vega, Pablo and de Castro, Luisa and Labarga, Fernando and Mesonero, Francisco and Castro-Poceiro, Jesús and Ponferrada-Díaz, Angel and Brunet-Mas, Eduard and Sesé, Eva and Ramos, Laura and Quiñones, Marta and Ruiz-Cerulla, Alexandra and Castro, Beatriz and Zabana, Yamile and Iglesias, Eva and Latras, Irene and Varela, Pilar and Ricart, Elena and Madero, Lucía and Elosua, Alfonso and Vicente, Laura and Lorente, Rufo and Betoré, Elena and Roig, Cristina and Mañosa, Míriam and Domènech, Eugeni and PERICO-ENEIDA Study of the GETECCU, PERICO-ENEIDA Study of the GETECCU},
  title = {Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  volume = {32},
  number = {11},
  pages = {2169--2178},
  doi = {10.1093/ibd/izag120}
}
Kostenlos starten →